You're reading the free version. Trader adds the live tape and alerts.
Start tracking
GPCR Sale Disclosure
Lin Xichen · SEC Form 4 · Filed Sep 2, 2026
Sale
Calculated transaction value
$59.62K
Lin Xichen Chief Scientific Officer
GPCR
Transaction date
Sep 1, 2026
Public filing date
Sep 2, 2026
Filing lag
Filed 1 day later
GPCR daily price context
Close on/before transaction
$47.13
Sep 1, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- American Depositary Shares on Ordinary Shares
- Quantity / price
- 1,300 shares @ $45.86
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001962926-26-000009
Filing cohort
Transactions in this filing
Showing 7 of 7
Trades
7
Issuers
1
Estimated value
$284.72K
Buys / sales
0 / 3
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Structure Therapeutics Inc. GPCR | Exercise | Sep 1, 2026 | $6.06K |
| Structure Therapeutics Inc. GPCR | Sale | Sep 1, 2026 | $214.25K |
| Structure Therapeutics Inc. GPCR Current | Sale | Sep 1, 2026 | $59.62K |
| Structure Therapeutics Inc. GPCR | Conversion | Sep 1, 2026 | $0 |
| Structure Therapeutics Inc. GPCR | Exercise | Sep 1, 2026 | $0 |
| Structure Therapeutics Inc. GPCR | Conversion | Sep 1, 2026 | $0 |
| Structure Therapeutics Inc. GPCR | Sale | Sep 1, 2026 | $4.78K |